Wegovy is a registered trademark of Novo Nordisk A/S. It is an FDA-approved prescription medicine, and a licensed clinician decides whether it is appropriate for a patient.
No website can tell you whether your plan covers a given prescription. The answer lives in your own plan documents, and it can differ from your neighbor's answer even when both of you carry a card from the same insurance company. This page shows you where the answer is kept and how to read it.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Risk information first
Wegovy carries a boxed warning about the risk of thyroid C-cell tumors. In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid carcinoma, in people.
It should not be used by anyone with a personal or family history of medullary thyroid carcinoma, or by anyone with Multiple Endocrine Neoplasia syndrome type 2. Serious risks described in the labeling include inflammation of the pancreas, gallbladder problems, low blood sugar, kidney injury, serious allergic reactions, suicidal behavior or thinking, and changes in vision in people with type 2 diabetes. Nausea, vomiting, diarrhea, and constipation are commonly reported.
Read the official Wegovy Prescribing Information and Medication Guide for the complete boxed warning, contraindications, warnings, and adverse reactions. A coverage answer is a financial answer. It is not a clinical one.
Who actually makes the decision
People picture one company deciding. In practice several parties each control a piece.
An employer or plan sponsor buys a benefit package and chooses which categories of medicine that package includes. Weight-management medicines are one of the categories a sponsor can include or leave out entirely.
A pharmacy benefit manager administers the drug benefit and maintains the formulary, which is the list of covered medicines and the tier each one sits on. The formulary also carries the rules attached to a medicine, such as prior authorization or step therapy.
Your health plan applies its own medical criteria when a review is required, and it issues the approval or the denial.
The pharmacy processes the claim and tells you the amount due at that moment. Government programs sit under their own separate rules.
Because the sponsor and the administrator both influence the outcome, a general article about a brand cannot answer a question about your benefits.
The four documents that hold your answer
Your formulary or drug list for the current year. This is the first place to look. Find your plan's member portal and search for the exact product name. Note the tier and every symbol beside it, because those symbols usually flag prior authorization, step therapy, or quantity limits. Formularies change at renewal, so confirm you are reading the current year.
Your summary of benefits and coverage. This shows the structure, including your deductible, your cost share by tier, and your out-of-pocket maximum. It tells you whether you are in the part of the year where you pay full cost toward a deductible.
Your plan's clinical policy or coverage criteria. When a medicine requires review, the plan publishes what it wants to see. Reading it before the request goes in is the single best way to avoid a delay.
Your denial notice, if there is one. A denial has to state the reason and explain your appeal rights and the deadline. That letter, not a phone call, is the document that tells you what to do next.
Making the calls in the right order
Call member services first, using the number on your card. Ask whether the product is on the current formulary, what tier it sits on, which requirements apply, what your cost share would be at an in-network pharmacy, whether your deductible currently applies, and whether a specific pharmacy is preferred. Write down the date and the representative's name.
Then ask a pharmacy to process or estimate the claim once a prescription exists. A processed claim is the clearest answer available, though it can change if your deductible status or plan terms change.
If a review is required, ask your clinician's office what documentation the plan wants and confirm it matches the published criteria. Incomplete submissions are a common reason for delay.
If an approval comes through, note its end date. Approvals are often granted for a limited period, and starting a renewal early is much easier than discovering the lapse at a pharmacy counter.
What the words on the formulary mean
Prior authorization means the plan wants clinical information before it agrees to pay. Step therapy means the plan expects something else to be tried first, unless an exception applies. A quantity limit caps how much can be dispensed in a period.
An exclusion is different from all of those. An exclusion means the category was not purchased as part of the benefit at all. In that case the path is usually a formulary exception request or an employer-level conversation with human resources or the benefits administrator, rather than a clinical review.
Knowing which of these applies to you changes who you talk to next, which is why the formulary symbols are worth reading carefully.
Where Body Good fits
Body Good provides clinical and administrative services. A licensed clinician reviews your history and decides what is appropriate. A program can include follow-up, coverage support, and routing a prescription to a state-licensed pharmacy.
Coverage support means running a benefit check and helping prepare the paperwork your plan requests. It is assistance with the process only. Approval and payment are determined by your plan, not by Body Good. No service can promise an approval, and you should be wary of one that suggests otherwise.
Body Good's prices are service fees for the program described during intake. They are not the price of medication, and the cost of medication is separate and not included. They are not a quote for any individual, and eligibility is determined by a clinician.
This website is an information and pricing overview. It takes no payment, collects no protected health information, and hosts no intake form. Intake and checkout take place on joinbodygood.com.
If the answer comes back no
Ask for the reason in writing, then work out which kind of no it is. A clinical denial can often be appealed with more information, and your clinician may be able to request a peer review if the plan offers one. An exclusion is a benefit design question for your employer.
Ask about self-pay routes as well. Novo Nordisk publishes current savings and patient-support terms through its official channels, including NovoCare. Programs carry eligibility rules, maximum benefits, and end dates, and people in government programs are often excluded, so read the current terms rather than an advertisement.
Ask whether paying cash counts toward your deductible or out-of-pocket maximum. Often it does not, and confirming that early prevents a surprise later in the plan year.
Then go back to the clinical question, which is the more important one. Ask your clinician what else is appropriate for you.
Frequently asked questions
Why does my friend have coverage when I do not?
Because benefits are set at the plan level. Two people with cards from the same insurance company can have different formularies, different rules, and different exclusions, depending on what each plan sponsor bought.
Does a prior authorization approval last forever?
Usually not. Approvals are often granted for a limited period and then need renewal. Note the end date when you receive the approval and start the renewal before it expires.
Can Body Good check my benefits for me?
Body Good can run a benefit check and help with the paperwork your plan requests. The plan makes the decision. Begin the secure intake to provide information for clinical review.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.